{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:26:10Z","timestamp":1765545970250,"version":"build-2065373602"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Heart Foundation Research Centre, the Griffith Health Institute"},{"name":"School of Medical Science, Griffith University, Australia"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.steroids.2014.12.017","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T19:45:40Z","timestamp":1419882340000},"page":"60-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats"],"prefix":"10.1016","volume":"94","author":[{"given":"Daniel G.","family":"Donner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belinda R.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C.","family":"Bulmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred K.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene F.","family":"Du Toit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.steroids.2014.12.017_b0005","first-page":"873","article-title":"Selective androgen receptor modulators: in pursuit of tissue-selective androgens","volume":"7","author":"Omwancha","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.steroids.2014.12.017_b0010","first-page":"99","article-title":"Synthetic anabolic agents: steroids and nonsteroidal selective androgen receptor modulators","author":"Thevis","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.steroids.2014.12.017_b0015","first-page":"355","article-title":"Hormonal growth promoting agents in food producing animals","author":"Stephany","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.steroids.2014.12.017_b0020","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1289\/ehp.011091145","article-title":"The fate of trenbolone acetate and melengestrol acetate after application as growth promoters in cattle: environmental studies","volume":"109","author":"Schiffer","year":"2001","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.steroids.2014.12.017_b0025","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1002\/etc.5620220623","article-title":"Effects of the androgenic growth promoter 17-beta-trenbolone on fecundity and reproductive endocrinology of the fathead minnow","volume":"22","author":"Ankley","year":"2003","journal-title":"Environ Toxicol Chem"},{"key":"10.1016\/j.steroids.2014.12.017_b0030","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1177\/0960327111408152","article-title":"New onset diabetes associated with bovine growth hormone and testosterone abuse in a young body builder","volume":"30","author":"Geraci","year":"2011","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.steroids.2014.12.017_b0035","first-page":"1077","article-title":"Rhabdomyolysis in a bodybuilder using steroids","volume":"150","author":"Daniels","year":"2006","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/j.steroids.2014.12.017_b0040","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2527\/jas.2012-5214","article-title":"Effects of estradiol benzoate and trenbolone acetate, alone or in combination at dose levels present in Synovex choice, on performance by feedlot heifers","volume":"91","author":"Cleale","year":"2013","journal-title":"J Anim Sci"},{"key":"10.1016\/j.steroids.2014.12.017_b0045","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.2527\/jas.2010-2901","article-title":"Effects of ractopamine and trenbolone acetate implants with or without estradiol on growth performance, carcass characteristics, adipogenic enzyme activity, and blood metabolites in feedlot steers and heifers","volume":"88","author":"Bryant","year":"2010","journal-title":"J Anim Sci"},{"key":"10.1016\/j.steroids.2014.12.017_b0050","first-page":"670","article-title":"Distribution of trenbolone residues in liver and various muscle groups of heifers that received multiple implants at the recommended site of application","volume":"91","author":"MacNeil","year":"2008","journal-title":"J AOAC Int"},{"key":"10.1016\/j.steroids.2014.12.017_b0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.bone.2012.07.008","article-title":"17beta-Hydroxyestra-4,9,11-trien-3-one (trenbolone) preserves bone mineral density in skeletally mature orchiectomized rats without prostate enlargement","volume":"51","author":"McCoy","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.steroids.2014.12.017_b0060","doi-asserted-by":"crossref","first-page":"E650","DOI":"10.1152\/ajpendo.00440.2010","article-title":"17beta-Hydroxyestra-4,9,11-trien-3-one (trenbolone) exhibits tissue selective anabolic activity: effects on muscle, bone, adiposity, hemoglobin, and prostate","volume":"300","author":"Yarrow","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.12.017_b0065","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.steroids.2010.01.019","article-title":"Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): a potent anabolic steroid with reduced androgenic and estrogenic activity","volume":"75","author":"Yarrow","year":"2010","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.12.017_b0070","first-page":"132","article-title":"Metabolic syndrome","volume":"36","author":"Reaven","year":"2004","journal-title":"J Insur Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2605.1997.d01-285.x","article-title":"Prevalence and risk factors for anabolic-androgenic steroid abuse in Australian high school students","volume":"20","author":"Handelsman","year":"1997","journal-title":"Int J Androl"},{"key":"10.1016\/j.steroids.2014.12.017_b0080","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3949\/ccjm.74.5.341","article-title":"Anabolic steroid abuse: psychiatric and physical costs","volume":"74","author":"Talih","year":"2007","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0085","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11920-002-0086-6","article-title":"Anabolic steroid abuse and dependence","volume":"4","author":"Brower","year":"2002","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.steroids.2014.12.017_b0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/eurpub\/ckn062","article-title":"Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes","volume":"18","author":"Tahtamouni","year":"2008","journal-title":"Eur J Pub Health"},{"key":"10.1016\/j.steroids.2014.12.017_b0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3810\/psm.2009.12.1751","article-title":"Anabolic steroid abuse and dependence in clinical practice","volume":"37","author":"Brower","year":"2009","journal-title":"Phys Sportsmed"},{"key":"10.1016\/j.steroids.2014.12.017_b0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/10826084.2011.630225","article-title":"Nonprescription steroids on the internet","volume":"47","author":"Clement","year":"2012","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.steroids.2014.12.017_b0105","doi-asserted-by":"crossref","first-page":"742","DOI":"10.3109\/10826084.2010.534123","article-title":"Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders","volume":"46","author":"Santos","year":"2011","journal-title":"Subst Use Misuse"},{"key":"10.1016\/j.steroids.2014.12.017_b0110","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2013-202472","article-title":"Iatrogenic dependence of anabolic-androgenic steroid in an Indian non-athletic woman","author":"Tripathi","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.steroids.2014.12.017_b0115","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drudis.2007.01.003","article-title":"Expanding the therapeutic use of androgens via selective androgen receptor modulators (SARMs)","volume":"12","author":"Gao","year":"2007","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.steroids.2014.12.017_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsbmb.2011.04.003","article-title":"Anabolic and androgenic activities of 19-nor-testosterone steroids: QSAR study using quantum and physicochemical molecular descriptors","volume":"126","author":"Alvarez-Ginarte","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.12.017_b0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.steroids.2008.10.016","article-title":"Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. Applied modifications in the steroidal structure","volume":"74","author":"Fragkaki","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.12.017_b0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2011.06.002","article-title":"Recent developments in antiandrogens and selective androgen receptor modulators","volume":"352","author":"Haendler","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.017_b0135","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/bjp.2008.165","article-title":"Pharmacology of anabolic steroids","volume":"154","author":"Kicman","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.steroids.2014.12.017_b0140","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1210\/jcem.84.10.6122","article-title":"Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium","volume":"84","author":"Negro-Vilar","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.12.017_b0145","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxsci\/70.2.202","article-title":"In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant","volume":"70","author":"Wilson","year":"2002","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.steroids.2014.12.017_b0150","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jama.2012.259","article-title":"The role of 5alpha-reductase inhibition in men receiving testosterone replacement therapy","volume":"307","author":"Gruntmanis","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.steroids.2014.12.017_b0155","doi-asserted-by":"crossref","first-page":"530121","DOI":"10.1155\/2012\/530121","article-title":"The 5 alpha-reductase isozyme family: a review of basic biology and their role in human diseases","volume":"2012","author":"Azzouni","year":"2012","journal-title":"Adv Urol"},{"key":"10.1016\/j.steroids.2014.12.017_b0160","doi-asserted-by":"crossref","first-page":"291","DOI":"10.33549\/physiolres.931999","article-title":"The effects of gender and obesity on myocardial tolerance to ischemia","volume":"60","author":"Clark","year":"2011","journal-title":"Physiol Res"},{"key":"10.1016\/j.steroids.2014.12.017_b0165","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.steroids.2014.12.017_b0170","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3177\/jnsv.56.109","article-title":"Visceral fat is a strong predictor of insulin resistance regardless of cardiorespiratory fitness in non-diabetic people","volume":"56","author":"Usui","year":"2010","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.steroids.2014.12.017_b0175","first-page":"624","article-title":"The laboratory rat: relating its age with human\u2019s","volume":"4","author":"Sengupta","year":"2013","journal-title":"Int J Prev Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0180","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.nut.2005.04.002","article-title":"Comparing rat\u2019s to human\u2019s age: how old is my rat in people years?","volume":"21","author":"Quinn","year":"2005","journal-title":"Nutrition"},{"key":"10.1016\/j.steroids.2014.12.017_b0185","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2119\/2008-00004.Ray","article-title":"Sex steroids and stem cell function","volume":"14","author":"Ray","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0190","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1089\/ten.2006.12.2747","article-title":"Modulations of 17-beta estradiol on osteogenic and adipogenic differentiations of human mesenchymal stem cells","volume":"12","author":"Hong","year":"2006","journal-title":"Tissue Eng"},{"key":"10.1016\/j.steroids.2014.12.017_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1385\/ENDO:15:2:225","article-title":"Estrogen receptors in human preadipocytes","volume":"15","author":"Joyner","year":"2001","journal-title":"Endocrine"},{"key":"10.1016\/j.steroids.2014.12.017_b0200","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1055\/s-2007-970417","article-title":"Site-specific effect of estradiol on gene expression in the adipose tissue of ob\/ob mice","volume":"39","author":"Shinozaki","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.steroids.2014.12.017_b0205","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1210\/endo-126-2-1229","article-title":"The effects of androgens on the regulation of lipolysis in adipose precursor cells","volume":"126","author":"Xu","year":"1990","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2014.12.017_b0210","doi-asserted-by":"crossref","first-page":"C1645","DOI":"10.1152\/ajpcell.1998.274.6.C1645","article-title":"Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids","volume":"274","author":"Dieudonne","year":"1998","journal-title":"Am J Physiol"},{"issue":"Suppl. 2","key":"10.1016\/j.steroids.2014.12.017_b0215","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1038\/sj.ijo.0801280","article-title":"The adipose tissue metabolism: role of testosterone and dehydroepiandrosterone","volume":"24","author":"De Pergola","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.steroids.2014.12.017_b0220","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/j.1550-8528.1996.tb00255.x","article-title":"Influence of androgenicity on adipocytes and precursor cells in female rats","volume":"4","author":"James","year":"1996","journal-title":"Obes Res"},{"key":"10.1016\/j.steroids.2014.12.017_b0225","first-page":"1041","volume":"11","author":"Gapstur","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.steroids.2014.12.017_b0230","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1111\/j.1532-5415.2006.00963.x","article-title":"Association between hormones and metabolic syndrome in older Italian men","volume":"54","author":"Maggio","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.steroids.2014.12.017_b0235","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/acel.12153","article-title":"Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism","volume":"13","author":"Akasaki","year":"2014","journal-title":"Aging Cell"},{"key":"10.1016\/j.steroids.2014.12.017_b0240","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1206168","article-title":"Gonadal steroids and body composition, strength, and sexual function in men","volume":"369","author":"Finkelstein","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0245","doi-asserted-by":"crossref","first-page":"R118","DOI":"10.1152\/ajpregu.00372.2013","article-title":"Effects of varying doses of testosterone on atherogenic markers in healthy younger and older men","volume":"306","author":"Roberts","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0250","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jsbmb.2011.08.005","article-title":"Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids","volume":"127","author":"Garevik","year":"2011","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.steroids.2014.12.017_b0255","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1097\/00005768-199602000-00004","article-title":"Lipoprotein (a) and cholesterol in body builders using anabolic androgenic steroids","volume":"28","author":"Cohen","year":"1996","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.steroids.2014.12.017_b0260","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0026-0495(84)90222-1","article-title":"Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic-androgenic steroids","volume":"33","author":"Webb","year":"1984","journal-title":"Metab Clin Exp"},{"key":"10.1016\/j.steroids.2014.12.017_b0265","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0022-2275(20)35359-1","article-title":"Relative effects of weight loss and dietary fat modification on serum lipid levels in the dietary treatment of obesity","volume":"34","author":"Leenen","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.steroids.2014.12.017_b0270","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/01.ATV.13.4.487","article-title":"Visceral fat loss measured by magnetic resonance imaging in relation to changes in serum lipid levels of obese men and women","volume":"13","author":"Leenen","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/j.steroids.2014.12.017_b0275","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","article-title":"The metabolic syndrome","volume":"365","author":"Eckel","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.steroids.2014.12.017_b0280","doi-asserted-by":"crossref","first-page":"32345","DOI":"10.1074\/jbc.M313478200","article-title":"Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease","volume":"279","author":"Samuel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.steroids.2014.12.017_b0285","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.steroids.2014.12.017_b0290","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2337\/diacare.26.8.2341","article-title":"Increased visceral fat and serum levels of triglyceride are associated with insulin resistance in Japanese metabolically obese, normal weight subjects with normal glucose tolerance","volume":"26","author":"Katsuki","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.steroids.2014.12.017_b0295","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1530\/eje.0.1480535","article-title":"Association between measures of insulin sensitivity and circulating levels of interleukin-8, interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men","volume":"148","author":"Bruun","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.017_b0300","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.etp.2008.09.007","article-title":"Heart lesions associated with anabolic steroid abuse: comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits","volume":"61","author":"Fanton","year":"2009","journal-title":"Exp Toxicol Pathol"},{"key":"10.1016\/j.steroids.2014.12.017_b0305","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/hrt.2003.015719","article-title":"Are the cardiac effects of anabolic steroid abuse in strength athletes reversible?","volume":"90","author":"Urhausen","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.steroids.2014.12.017_b0310","first-page":"411","article-title":"Androgenic anabolic steroid abuse and the cardiovascular system","author":"Vanberg","year":"2010","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.steroids.2014.12.017_b0315","doi-asserted-by":"crossref","first-page":"H1560","DOI":"10.1152\/ajpheart.01087.2002","article-title":"Estrogen and testosterone have opposing effects on chronic cardiac remodeling and function in mice with myocardial infarction","volume":"284","author":"Cavasin","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0320","doi-asserted-by":"crossref","first-page":"H2043","DOI":"10.1152\/ajpheart.01121.2005","article-title":"Testosterone enhances early cardiac remodeling after myocardial infarction, causing rupture and degrading cardiac function","volume":"290","author":"Cavasin","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0325","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.ijcard.2006.11.199","article-title":"Atrial fibrillation and anabolic steroid abuse","volume":"117","author":"Lau","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0330","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00414-005-0055-9","article-title":"Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders","volume":"121","author":"Fineschi","year":"2007","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0335","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0736-4679(99)00095-5","article-title":"Atrial fibrillation and anabolic steroids","volume":"17","author":"Sullivan","year":"1999","journal-title":"J Emerg Med"},{"key":"10.1016\/j.steroids.2014.12.017_b0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1677\/joe.1.06722","article-title":"Cardiac concentric remodelling induced by non-aromatizable (dihydro-)testosterone is antagonized by oestradiol in ovariectomized rats","volume":"189","author":"Tivesten","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.017_b0345","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1161\/01.CIR.98.3.256","article-title":"Androgen receptors mediate hypertrophy in cardiac myocytes","volume":"98","author":"Marsh","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.steroids.2014.12.017_b0350","first-page":"21","article-title":"Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia\/reperfusion injury","volume":"16","author":"Du Toit","year":"2005","journal-title":"Cardiovasc J S Afr"},{"key":"10.1016\/j.steroids.2014.12.017_b0355","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13685538.2012.754008","article-title":"Androgen modulates cardiac fibrosis contributing to gender differences on heart failure","volume":"16","author":"Chung","year":"2013","journal-title":"Aging Male"},{"key":"10.1016\/j.steroids.2014.12.017_b0360","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/nrendo.2013.73-c1","article-title":"Testosterone therapy and cardiovascular events","volume":"9","author":"Schooling","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.steroids.2014.12.017_b0365","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1097\/SMJ.0b013e3182749269","article-title":"Androgen abuse and increased cardiac risk","volume":"105","author":"Higgins","year":"2012","journal-title":"South Med J"},{"key":"10.1016\/j.steroids.2014.12.017_b0370","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.steroids.2012.12.004","article-title":"Testosterone metabolites mediate its effects on myocardial damage induced by ischemia\/reperfusion in male Wistar rats","volume":"78","author":"Rubio-Gayosso","year":"2013","journal-title":"Steroids"},{"key":"10.1016\/j.steroids.2014.12.017_b0375","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1113\/expphysiol.2013.074948","article-title":"Myocardial structure, function and ischaemic tolerance in a rodent model of obesity with insulin resistance","volume":"98","author":"Wensley","year":"2013","journal-title":"Exp Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0380","first-page":"457","article-title":"Obesity improves myocardial ischaemic tolerance and RISK signalling in insulin-insensitive rats","volume":"6","author":"Donner","year":"2013","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.steroids.2014.12.017_b0385","doi-asserted-by":"crossref","first-page":"H2336","DOI":"10.1152\/ajpheart.00481.2007","article-title":"Myocardial susceptibility to ischemic\u2013reperfusion injury in a prediabetic model of dietary-induced obesity","volume":"294","author":"du Toit","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0390","article-title":"Prohormone supplement 3b-hydroxy-5a-androst-1-en-17-one enhances resistance training gains but impairs user health","author":"Granados","year":"2013","journal-title":"J Appl Physiol"},{"key":"10.1016\/j.steroids.2014.12.017_b0395","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004836-200210000-00013","article-title":"Androgenic\/anabolic steroid-induced toxic hepatitis","volume":"35","author":"Stimac","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.steroids.2014.12.017_b0400","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1590\/S0102-67202012000300010","article-title":"Giant hepatic adenoma associated with anabolic-androgenic steroid abuse: case report","volume":"25","author":"Pais-Costa","year":"2012","journal-title":"Arq Bras Cir Dig"},{"key":"10.1016\/j.steroids.2014.12.017_b0405","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.3748\/wjg.14.4573","article-title":"Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage","volume":"14","author":"Martin","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.steroids.2014.12.017_b0410","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.mehy.2008.12.042","article-title":"Anabolic steroid-induced hypogonadism \u2013 towards a unified hypothesis of anabolic steroid action","volume":"72","author":"Tan","year":"2009","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.steroids.2014.12.017_b0415","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1590\/S1677-5538.IBJU.2013.05.10","article-title":"The prostate after administration of anabolic androgenic steroids: a morphometrical study in rats","volume":"39","author":"Vargas","year":"2013","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.steroids.2014.12.017_b0420","doi-asserted-by":"crossref","first-page":"E222","DOI":"10.1152\/ajpendo.00305.2004","article-title":"Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects","volume":"288","author":"Borst","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.steroids.2014.12.017_b0425","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1464-410X.2007.06896.x","article-title":"Validation of the Pitts unified theory of prostate cancer, late-onset hypogonadism and carcinoma: the role of steroid 5alpha-reductase and steroid aromatase","volume":"100","author":"Pitts","year":"2007","journal-title":"BJU Int"}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X14003109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:02:21Z","timestamp":1758535341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X14003109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":85,"alternative-id":["S0039128X14003109"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.017","relation":{},"ISSN":["0039-128X"],"issn-type":[{"type":"print","value":"0039-128X"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improvements in body composition, cardiometabolic risk factors and insulin sensitivity with trenbolone in normogonadic rats","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2014.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}